16 filings
8-K
VOR
Vor Biopharma Inc
2 May 24
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
4:07pm
8-K
VOR
Vor Biopharma Inc
5 Jan 24
Other Events
5:03pm
8-K
VOR
Vor Biopharma Inc
2 Nov 23
Multiple Clinical and Preclinical Presentations at ASH 2023
9:10am
8-K
VOR
Vor Biopharma Inc
9 Jun 23
Regulation FD Disclosure
7:41am
8-K
VOR
Vor Biopharma Inc
26 May 23
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
vqy4n61m1dxjdpzfllg5
14 Apr 23
Departure of Directors or Certain Officers
4:01pm
8-K
h85qofghwu0 kqm
16 Feb 23
Regulation FD Disclosure
12:13pm
8-K
mhw9tq7ghi0mp 2u2h
23 Dec 22
Entry into a Material Definitive Agreement
4:07pm
8-K
r34czfttc1x2
14 Dec 22
Termination of a Material Definitive Agreement
4:32pm
8-K
h4p8ypp2oiyp6x6pb0
7 Dec 22
Vor Bio Prices Underwritten Offering of Common Stock and Concurrent
4:59pm
8-K
gree0ofm2za9bon9mmb
7 Dec 22
Regulation FD Disclosure
7:36am
8-K
pwxzym13776xy
29 Nov 22
Regulation FD Disclosure
10:25am
8-K
l7yrig3wbkg30e4yhl6w
17 Jun 22
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
1j222ejipp
14 Apr 22
Departure of Directors or Certain Officers
4:01pm
8-K
5lp3yitpd0qftzng0s
17 Jun 21
Entry into a Material Definitive Agreement
8:13am
8-K
v55kr4lyi91t5o dns11
9 Feb 21
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to
4:21pm
- Prev
- 1
- Next